InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: None

Friday, 04/29/2016 12:40:19 AM

Friday, April 29, 2016 12:40:19 AM

Post# of 402945
While on topic of correcting things, I went to SA and corrected a massive error. Please like the comment over there if you agree.

http://seekingalpha.com/article/3966366-can-cellceutix-emerge-shadows-limelight?v=1461867887&commenter=1

Hope4Future… Let’s keep it simple and show what utter nonsense your posted link is. Due to lack of time, I’ll just give you one glaring fact:

Your link states that Dr Frei and Dr Khorana had never heard of cellcuetix.

Exhibit 20 filed on 2.10.16 as part of a response to a frivolous lawsuit filed against Cellceutix using some of the same arguments used over here show that Dr. Emil Frei, director and physician-in-chief emeritus at the Dana Faber Cancer Institute, and Dr. Har Gobind Khorana, a 1968 Nobel Prize Winner were founding shareholders of Cellceutix as evidenced by the Stock Transfer Agent Report. Link follows.

https://ecf.nysd.uscourts.gov/doc1/127117615749

https://ia601507.us.archive.org/4/items/gov.uscourts.nysd.447344/gov.uscourts.nysd.447344.docket.html

Your link is utter fantasy that no matter how many times it’s copied over and repeated won’t become truth.

**********
May Dr Frei RIP.

http://www.dana-farber.org/Newsroom/News-Releases/Remembering-Dr--Emil-Frei,-III.aspx

Remembering Dr. Emil Frei III
Emil "Tom" Frei III, MD, who served as Dana-Farber physician-in-chief and whose work led to some of the first cures for a variety of pediatric and adult cancers, passed away on April 30 at age 89.







To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News